文献速递脑血管病

CHA2DS2-VASc评分在亚洲房颤患者卒中风险中的验证:韩国全国样本队列研究

CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study.
PubMed 文献 · Stroke · 2017-04-28

结果显示缺血性卒中总发生率为3.32/100人年,低危患者为0.23,高危患者为4.59,且事件率随评分升高而增加。多因素分析中血管疾病和糖尿病的显著性减弱,女性风险低于男性(HR 0.73)。结论认为CHA2DS2-VASc评分在亚洲人群中的表现与西方人群相当,能良好识别真低危房颤患者。

要点

  • CHA2DS2-VASc评分在亚洲房颤患者中表现与西方人群相当
  • 低危患者(评分0男/1女)年卒中事件率持续低于1%
  • 女性缺血性卒中风险低于男性(HR 0.73,95%CI 0.64-0.84)

核心结论

  • CHA2DS2-VASc评分在亚洲人群中的表现与西方人群相当,能良好定义真低危房颤患者。

主要发现

  • 缺血性卒中总发生率为3.32/100人年,低危患者(CHA2DS2-VASc评分0男或1女)为0.23/100人年,高危患者(评分≥2)为4.59/100人年。
  • 缺血性卒中或复合血栓栓塞终点发生率随CHA2DS2-VASc评分升高而明显增加。
  • 多因素分析中,血管疾病或糖尿病的显著性在多变量调整后减弱,女性性别与缺血性卒中风险较低相关(HR 0.73,95%CI 0.64-0.84)。
  • 被归类为低危的患者事件率持续低于每年1%。

关键数值与推荐

  • 低危定义为CHA2DS2-VASc评分0(男性)或1(女性),高危定义为评分≥2。

临床怎么用

  • 在亚洲房颤患者中可使用CHA2DS2-VASc评分进行卒中风险分层,评分低危者卒中风险低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The CHA2DS2-VASc stroke score (congestive heart failure, hypertension, age ≥75 (doubled), diabetes mellitus, prior stroke or transient ischemic attack (doubled), vascular disease, age 65-74, female) is used in most guidelines for risk stratification in atrial fibrillation (AF), but most data for this score have been derived in Western populations. Ethnic differences in stroke risk may be present. Our objective was to investigate risk factors for stroke in AF and application of the CHA2DS2-VASc score in an Asian AF population from Korea. METHODS: A total of 5855 oral anticoagulant-naive nonvalvular AF patients aged ≥20 years were enrolled from Korea National Health Insurance Service Sample cohort from 2002 to 2008 and were followed up until December 2013. RESULTS: The incidence rates (per 100 person-years) of ischemic stroke were 3.32 in the total population, being 0.23 in low-risk (CHA2DS2-VASc score 0 [male] or 1 [female]) and 4.59 in high-risk patients (CHA2DS2-VASc ≥2). Incidence rates of ischemic stroke or the composite thromboembolism end point showed a clear increase with increasing CHA2DS2-VASc score. On multivariable analysis, significant associations between CHA2DS2-VASc risk factors and ischemic stroke were observed; however, the significance of vascular disease or diabetes mellitus was attenuated after multivariate adjustment, and female sex (hazard ratio, 0.73; 95% confidence interval, 0.64-0.84) had a lower risk of ischemic stroke than males. Patients who were categorized as low risk consistently had an event rate <1% per year. CONCLUSIONS: The performance of CHA2DS2-VASc score in Asians is comparable with that in Western populations. The score shows good performance in defining the truly-low-risk AF patients for stroke/thromboembolism.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Kim TH, Yang PS, Uhm JS, et al. CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study. Stroke. 2017. PMID: 28455320. doi:10.1161/STROKEAHA.117.016926

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。